GW Pharmaceuticals CEO Justin Gover discusses how the company secured FDA approval for its cannabis-derived drug and what it says referring to the capacity forward for cannabis-derived treatment.
GW Pharma CEO on recent cannabis-derived drug
Tweet on Twitter
Share on Facebook
Pinterest
